公司問答 | 春雪食品:公司目前委託養殖基地批次存欄規模1400萬隻
格隆匯6月19日丨有投資者在互動平台向春雪食品提問:公司的肉雞總體養殖規模目前存欄量大概多少隻,公司和農户養殖規模佔比分別是多少,能否滿足自身需求,養殖類和食品加工類的利潤比分別是多少?春雪食品迴應:公司目前委託養殖基地批次存欄規模1400萬隻,全部是農户養殖,可以滿足公司目前宰殺需求;2023年末,計劃達到1560萬隻,年出欄量在1億隻左右,可以滿足滿產宰殺需求。根據公司年報,2022年度調理品毛利率是16.6%,生鮮品毛利率為1.8%,毛雞毛利率為4.85%,由於公司一體化產業鏈的特性,如此劃分的利潤比意義並不大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.